WS-04 Designs for Targeted Therapies
Howard West (USA), Jack Lee (USA), John Crowley (USA)

WS-04-01 Designs for Targeted Therapies
Howard West (USA)

WS-04-02 Novel clinical trial design applying Bayesian adaptive randomization for targeted therapy in lung cancer - A step toward personalized medicine
Jack Lee (USA)

WS-05 High Dimensional Markers
Fred R. Hirsch , Yu Shyr (USA)

WS-05-02 Biostatistical and Bioinformatics Approaches in High Dimensional Data Derived from High Throughput Assays: A Consumer Guide
Yu Shyr (USA)

WS-06 Pharmacogenomics
David Gandara (USA), Satoshi Teramukai (Japan)

WS-06-01 Pharmacogenomics
David Gandara (USA)

WS-06-02 Statistical Comments on pharmacogenomic analysis
Satoshi Teramukai (Japan)

Biostatistics & Clinical Design Workshop Reception, Dinner and Panel Discussions

Opportunities for Lung Cancer Trials in Asia
Byung-Ho Nam (South Korea), Benny Zee (China), Satoshi Teramukai (Japan), Kyung Mann Kim (USA)

Models for Clinical Trials Conduct and Management
John Crowley (USA), Satoshi Teramukai (Japan), Howard West (USA), Byung-Ho Nam (South Korea)

Lung Cancer Screening
Session: MTP1
Chair: Rob van Klaveren (Netherlands)
MTP1-01 International Early Lung Cancer Action Program
Professor: Claudia I. Henschke (USA)

Bronchioloalveolar Carcinoma (BAC)
Session: MTP2
Chair: Masayuki Noguchi (Japan)
MTP2-01 Bronchioloalveolar Carcinoma
Professor: Wilbur A. Franklin (USA)

VATS Minimally Invasive & Robotic Surgery
Session: MTP3
Chair: Thomas D’Amico (USA)
MTP3-01 Robotic-assisted VATS Lobectomy
Professor: Bernard J. Park (USA)

Small Cell Lung Cancer Therapy
Session: MTP4
Chair: Karen Kelly (USA)
MTP4-01 Small Cell Lung Cancer
Professor: Nevin Murray (Canada)

Clinical Trial Methodology for Targeted Agents
Session: MTP5
Chair: John Drowley (USA)
MTP5-01 Clinical trials methodology for targeted agents
Professor: Marianne Paesmans (Belgium)

Stereotactic Radio Surgery
Session: MTP6
Chair: Kazushige Hayakawa (Japan)
MTP6-01 Stereotactic Radio Surgery
Professor: Robert Timmerman (USA)

PLENARY 1
Tobacco or Health?
Session: PL1
Chairs: Desmond Carney (Ireland) & Jin Soo Lee (South Korea)

08:20

08:45

09:10

09:35

PL1-01 The Epidemiology of Lung Cancer: What we know and what we need to know
Jonathan Samet (USA)
PL1-02 Smoking cessation in practice
Carolyn Dresler (USA)
PL1-03 Garnering Global Support: the WHO FCTC as a Cancer Prevention Tool
Douglas Bettcher (Switzerland)
PL1-04 Banning the Tobacco
Jae-Gahb Park (South Korea)

Understanding the Cultural Heritage of Korea

Hong June You, Administrator, Cultural Heritage Administration

MINI SYMPOSIA SESSIONS

Surgery in Special Situations
Session: M01
Chairs: Dominique H. Grunenwald (France) & Sanghoon Jheon (South Korea)
10:35 M01-01 2nd primaries
Paul De Leyn (Belgium)
11:05 M01-02 Treatment for the Screen-detected Lung Cancer: Characteristics and Outcome
Hisao Asamura (Japan)
11:35 M01-03 Surgery in multimodality therapy
Mark J. Krasna (USA)

Translational Research in Radiation Oncology
Session: M02
Chairs: Noah C. Choi (USA) & David Raben (USA)
10:35 M02-01 FDG-PET & Tumor response
Michael MacManus (Australia)
10:55 M02-02 Combined radiation and targeted therapy
David Raben (USA)
11:15 M02-03 Tumor Hypoxia and Metastasis in Non-Small Cell Lung Cancers
Quynh-Thu Le (USA)
11:35 M02-04 Genetic markers of tumor response
Eun Kyung Choi (South Korea)

Molecular Predictors of EGFR TKIs
Session: M03
Chairs: Thomas Lynch (USA) & Guiseppe Giaccone (USA)
10:35 M03-01 Molecular Predictors of EGFR TKIs
Tetsuya Mitsudomi (Japan)
10:55 M03-02 Molecular Predictors for Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR TKIs)
Federico Capuzzo (Italy)
11:15 M03-03 K-ras Mutations
John V. Heymach (USA)
11:35 M03-04 Proteins
Rafal Dziadziuszko (Poland)

Dilemmas of Advanced Technology
*Interactive Grand Round 1 Session: M04
Chairs: James R. Jett (USA) & Nevin Murray (Canada)
10:35 M04-01 Severe dysplasia detected on AFB
Norihiko Ikeda (Japan)
11:05 M04-02 Evaluation of Ditzels detected at CT screening
David Midthun (USA)
11:35 M04-03 Lymph node mapping by EBUS-TBNA
Kazuhiro Yasufuku (Japan)

Characterization of Pulmonary Nodules
Session: M05
Chairs: Kiyoshi Murata (Japan) & Jeremy Erasmus (USA)
10:35 M05-01 Nodule detection using computer assisted diagnosis
Giulia Veronesi (Italy)
11:05 M05-02 Nodule characterization: CT and PET
Jeremy Erasmus (USA)
11:35 M05-03 Significance of GGO in malignant pulmonary nodule
Yasuo Nakajima (Japan)

Molecular Predictors and Prognosticators
Session: M06
Chairs: Nagahiro Saijo (Japan) & Rafael Rosell (Spain)
10:35 M06-01 ERCC1 Expression and Akin DNA Repair Genes
Rafael Rosell (Spain)
10:55 M06-2 RRM1-a predictive and prognostic marker for patients with NSCLC
Gerold Bepler (USA), presented by Zhong Zheng (USA)
11:15 M06-03 Prediction of benefit from EGFR TKIs by proteomic analysis of pretreatment Serum
David Carbone (USA)
11:35 M06-04 Genomic Signatures of Prognosis in Early Stage Non-Small Cell Lung Cancer
Ming Sound Tsao (Canada)

Combined Modality Therapy in NSCLC I
Session: A1
Chair: Noah C. Choi (USA)
Co-Chair: David Ball (Australia)

Imaging - Prognostic Determinants
Session: A2
Chair: Reginald Munden (USA)
Co-Chair: Jin Mo Goo (South Korea)

Cytotoxic Chemotherapy I
Session A3
Chair: Philip Bonomi (USA)
Co-Chair: Alex Y. Chang (Singapore)

Surgery
Session: A4
Chair: Valerie Rusch (USA)
Co-Chair: Joo Hyun Kim (South Korea)
Discussants: Yukitio Ichinose (Japan) & Joe B. Putnam (USA)

Molecular Targets
Session: A5
Chair: David Carbone (USA)
Co-Chair: Myung Ju Ahn (South Korea)

Cancer Genetics and Tumor Biology
Session: A6
Chair: Thomas Lynch (USA)
Co-Chair: Enriqueta Felip (Spain)

Prevention & Early Detection
Session: A7
Chair: Thomas G. Sutedja (Netherlands)
Co-Chair: Keith Robert (USA)

POSTER DISCUSSION SESSION 1
Session: PD1
Chair: Theresa McLoud (USA)
Co-Chair: James Mulshine (USA)

PD1-1: Epidemiology and Prevention & Early Detection
Discussant Prevention & Early Detection: James R. Jett (USA)
Discussant Epidemiology: Gary Strauss (USA)
PD1-2: EUS and PET-CT in Lung Cancer Staging
Discussant: Deok Sik Kang (South Korea)
PD1-3: Pathology and Bronchoscopy
Discussants: Yasushi Yatabe (Japan), Pyng Lee (Singapore)

POSTER DISCUSSION SESSION 6
Session: PD6
Chair: John R. Eckardt (USA)
Co-Chair: Yi-Long Wu (China)

PD6-1: SCLC
Discussants: John R. Eckardt (USA)
PD6-2: Mesothelioma and other Thoracic Malignancy
Discussant: Antonio Torres Garcia (Spain)
PD6-3: Supportive Care & Quality-of-Life
Discussant: Sumitra Thongprasert (Thailand)

Mesothelioma
Session: E01
Chairs: Hiromi Wada (Japan) & Alex Adjei (USA)

16:05 E01-01 Pathogenesis and staging
Hedy Lee Kindler (USA)
16:25 E01-02 State of the Art Mesothelioma Diagnosis: A Moving Target
Victor Roggli (USA)
16:45 E01-03 Surgery and Multimodality therapy
Harvey I. Pass (USA)
17:05 E01-04 Systemic Therapy for advanced Mesothelioma
Michael J. Boyer (Australia)

Molecular Oncology: Implications for Clinical Practice
Session: E02
Chairs: Bruce Johnson (USA) & Rolf A. Stahel (Switzerland)

16:05 E02-01 Integrating morphology and genetics in lung cancer classification
Iver Petersen (Germany)
16:25 E02-02 Comprehensive risk modeling using prognostic and predictive markers
Ravi Salgia (USA)
16:45 E02-03 Molecular imaging for efficacy evaluation - Homer A. Macapinlac (USA)
17:05 E02-04 Molecular signatures of lung cancer
Pan-Chyr Yang (Taiwan)

What's new in Systemic Therapy?
Session: E03
Chairs: Peter Harper (UK) & Mark Kris (USA)

16:05E03-01 New cytotoxics
Ulrich Gatzemeier (Germany)
16:35E03-02 Beyond EGFR and VEGF
Suresh Ramalingam (USA)
17:05 E03-03 How to speed up developing new agents? Mark Kris (USA)

Advances in Surgical Staging
Session: E04
Chairs: Paul van Schil (Belgium) & Tomoyuki Goya (Japan)

16:05 E04-01 Mediastinal staging algorithm
Steven Keller (USA)
16:25 E04-02 Cervical Mediastinoscopy
Eric Vallieres (USA)
16:45 E04-03 Thoracoscopy or video-assisted thoracuc surgery (VATS)
Paul van Schil (Belgium)
17:05 E04-04 Re-do mediastinoscopy
Georgios Stamatis (Germany)

IASLC Staging Project
Session: E05
Chairs: Frances Shepherd (Canada) & Harubumi Kato (Japan)

16:05E05-01 The IASLC Lung Cancer Staging Project: The History
Peter Goldstraw (UK)
16:20E05-02 T-descriptors
Ramon Rami-Porta (Spain)
16:35E05-03 Proposals for the Revision of the N Descriptors in the TNM Classification for Lung Cancer: The IASLC Lung Cancer Staging Project
Valerie Rusch (USA)
16:50E05-03 M-descriptors
Pieter Postmus (Netherlands)
17:05E05-04 Prognostic factors
Jean-Paul Sculier (Belgium)
17:20 E05-05 SCLC
Desmond Carney (Ireland)

Management of Bone Metastasis
Session: E06
Chairs: Giorgio Scagliotti (Italy) & Joo-Hang Kim (South Korea)

16:05 E06-01 Pathogenesis of Lung Cancer Bone Metastasis
G. David Roodman (USA)
16:25 E06-02 Update on Bone Metastases and Biomarkers in Non-small Cell Lung Cancer
Peter Harper (UK)
16:45 E06-03 Management of Bone Metastasis - Role of Bisphosphonates
David Ettinger (USA)
17:05 E06-04 Surgical Treatment
Rickard Wedin (Sweden)

Treatment of Locally Advanced Non-Small Cell Lung Cancer
Session: E07
Chairs: James Rigas (USA) & Hak Choy (USA)

16:05E07-01 Combined Modality Therapy for Locally Advanced NSCLC
Hak Choy (USA)
16:35E07-02 Role of Surgery
Dominique H. Grunenwald (France)
17:05E07-03 Neoadjuvant or adjuvant CT, etc.
Everett E. Vokes (USA)

Combined Modality Therapy for NSCLC
Session: MTP7
Chair: Walter J. Curran (USA)
MTP7-01 Combined modality therapy for NSCLC
Professor: Jacek Jassem (Poland)

Non-Surgical Approaches (RFA)
Session: MTP8
Chair: Stephen Swisher (USA)
MTP8-01 Percutaneous Radiofrequency Ablation of Malignant Thoracic Tumors
Professor: Susumu Kanazawa (Japan)

Interventional Pulmonology
Session: MTP9
Chair: Eric Edell (USA)
MTP9-01 Interventional Pulmonology
Professor: Stefano Gasparini (Italy)

EGFR-Targeted Therapy
Session: MTP10
Chair: Chun-Ming Tsai (Taiwan)
MTP10-01 Impact of genomic changes on the treatment of lung cancer
Professor: Bruce Johnson (USA)

Pulmonary Toxicity of Therapy
Session: MTP11
Chair: Masahiro Fukuoka (Japan)
MTP11-01 Pulmonary Toxicity of Therapy
Professor: James R. Jett (USA)

Genomics and Proteomics in Lung Cancer
Session: MTP12
Chair: Takashi Takahashi (Japan)
MTP12-01 Genomics and Proteomics in Lung Cancer Professor: David Beer (USA)

08:15 - 10:00

08:20

08:50

09:20

PLENARY 2
Advances in Staging
Session: PL2
Chairs: Peter Goldstraw (UK) & Nagahiro Saijo (Japan)

PL2-01 IASLC staging project
Peter Goldstraw (UK)
PL2-02 Molecular Staging
Fred R. Hirsch (USA)
PL2-03 New imaging techniques (PET, PET/CT,MRI, E(B)US) for lung cancer staging and response assessment
Egbert Smit (Netherlands)

HIGHLIGHT OF THE DAY
Session: HOD1
10:30 Medical Oncology
Mark A. Socinski (USA)
10:50 Surgery
Jack Roth (USA)
11:10 Radiation Oncology
Raymond Pierre Abratt (South Africa)
11:30 Imaging
Jung-Gi Im (South Korea)
11:45 Prevention and Epidemiology
James Mulshine (USA)

Debate in Lung Cancer Surgery
*Interactive Grand Round 2 Session: M07
Chairs: Jhingook Kim (South Korea) & Ramon Rami-Porta (Spain)

10:35 M07-01 & M07-02 Pneumonectomy vs. sleeve resection
Jean Deslauriers (Canada) & E.A. Rendina (Italy)
11:15 M07-03 Lobectomy vs. limited resection for lung cancer
David Jablons (USA) & Masahiko Higashiyama (Japan)

Predictors for chemotherapy (toxicity and response)
Session: M08
Chairs: Rafael Rosell (Spain) & Jung Shin Lee (South Korea)

10:35 M08-01 Taxanes
David Gandara (USA)
10:55 M08-02 Topoisomerase I inhibitors
Nagahiro Saijo (Japan)
11:15 M08-03 Is there a role for Cox-2 inhibition in lung cancer?
Martin Edelman (USA)
11:35 M08-04 Retinoids and rexinoids in lung cancer biology and therapy
Fadlo Khuri (USA)

Lung Cancer Staging: State-of-the-Art Imaging Modality
Session: M09
Chairs: J. A. Verschakelen (Belgium) & Kyung Soo Lee (South Korea)

10:35 M09-01 Lung cancer staging with CT and MR: T, N and M factors
J.A. Verschakelen (Belgium)
10:55 M09-02 Mediastinal nodal staging: Integrated PET/CT
Reginald Munden (USA)
11:15 M09-03 Biomarkers and Risk Models for Stratification of High Risk Individuals
John Field (UK)
11:35 M09-04 Extrathoracic staging: whole body PET and MR Imaging
Kyung Soo Lee (South Korea)

Emerging Field of Lung Cancer Research
Session: M10
Chairs: Shujun Cheng (China) & John D. Minna (USA)

10:35 M10-01 Molecular Pathogenesis of Lung Cancer with Translation to the Clinic
John D. Minna (USA)
10:55 M10-02 Inflammation in lung carcinogenesis
Steven M. Dubinett (USA)
11:15 M10-03 Mouse Models of Lung Cancer
Ilona Linnoila (USA)
11:35 M10-04 Telomerase immortalized human bronchial epithelial cells (HBECs) have stem cell characteristics
Jerry Shay (USA)

Chemoprevention
Session: M11
Chairs: Waun Ki Hong (USA) & York E. Miller (USA)

10:35 M11-01 Molecular analysis of preinvasive lesions in search for new surrogate biomarkers of chemopreventive drug efficacy
Pierre Massion (USA)
10:55 M11-02 Lung Cancer Chemprevention in 2007
Nico van Zandwijk (Netherlands)
11:15 M11-03 Natural Agents for Chemoprevention
Young-Joon Surh (South Korea)
11:35 M11-04 Lung Cancer Chemoprevention Trials
Jenny T. Mao (USA)

EGFR/VEGF – Inhibitors in Combination with other Modalities
Session: M12
Chairs: Christian Manegold (Germany) & Masahiro Fukuoka (Japan)

10:35 M12-01 Combinations with anti VEGF
Roy Herbst (USA)
10:55 M12-02 EGFR inhibitors in combination
Roman Perez-Soler (USA)
11:15 M12-03 Pharmacodynamic separation
Angela Davies (USA)
11:35 M12-04 Zactima (ZD6474) in combination
Lucio Crino (Italy)

Clinico-radiologic-bronchoscopic-pathologic conference
*Interactive Grand Round 3 Session: M13
Chairs: Thomas G. Sutedja (Netherlands) & Henri Colt (USA)
Discussants: Theresa McLoud (USA) , Elizabeth Brambilla (France), Hojoong Kim (South Korea), Peter Goldstraw (UK), Frank J. Lagerwaard (Netherlands)

10:35 M13-01 Carcinoma in situ
Thomas G. Sutedja (Netherlands)
11:00 M13-02 GGO lesions
Theresa C. McLoud (USA)
11:25 M13-03 Another pulmonary nodule
Hojoong Kim (South Korea)

Lung Cancer in Women
Session: M16
Chairs: Kathy Albain (USA) & Jacqueline Whang-Peng (Taiwan)

10:35 M16-01 Role of Biology and Genetics in Lung cancer in Woman
Micheal Unger (USA)
10:55 M16-02 Risk factors for non-smoking women
Enriqueta Felip (Spain)
11:15 M16-03 Treatment and survival difference
Joan Schiller (USA)
11:35 M16-04 Women`s Smoking in the 21st Century
Ellen Gritz (USA)

Novel Therapeutics I
Session: B1
Chair: Nicholas Thatcher (UK)
Co-Chair: Masahiro Fukuoka (Japan)

Cytotoxic Chemotherapy II
Session: B2
Chair: Antoinette Wozniak (USA)
Co-Chair: Purvish Parikh (India)

Molecular Targeted Therapy: EGFR inhibitors
Session: B3
Chair: Giorgio Scagliotti (Italy)
Co-Chair: Nise Yamaguchi (Brazil)

Prevention & Early Detection + Epidemiology
Session: B4
Chair: James Bishop (Australia)
Co-Chair: Tomotaka Sobue (Japan)

NSCLC: New Paradigm in Radiation Therapy
Session: B5
Chair: Andrew Turrisi (USA)
Co-Chair: Chang Kin Liam (Malaysia)

Health Services, Supportive Care & QOL
Session: B6
Chair: Michael Cullen (UK)
Co-Chair: Richard Gralla (USA)

BSTB: Molecular Diagnostics & Pathology
Session: B7
Chair: Elizabeth Brambilla (France)
Co-Chair: Dinesh Doval (India)

POSTER DISCUSSION SESSION 2
Session: PD2
Chair: Tetsuya Mitsudomi (Japan)
Co-Chair: Jean-Charles Soria (France)

PD2-1: Cancer Genetics and Tumor Biology
Discussant: Federico Cappuzzo (Italy), Adi Gazdar (USA)
PD2-2: Molecular Pathology
Discussant: Silvia Novello (Italy)
PD2-3: Molecular Targets and Prognostic Factors
Discussant: Pasi A. Janne (USA)

POSTER DISCUSSION SESSION 4
Session: PD 4
Chair: Jean-Yves Douillard (France)
Co-Chair: Nobuyuki Yamamoto (Japan)

PD4-1: Combined Modality Therapy in NSCLC
Discussant: Hak Choy (USA)
PD4-2: Cytotoxic Chemotherapy I
Discussant: Rolf A. Stahel (Switzerland)
PD4-3: Cytotoxic Chemotherapy II
Discussant: Philip Bonomi (USA)

New Technology for Diagnosis
Session: E08
Chairs: Stephen C. Lam (Canada) & Takehiko Fujisawa (Japan)

16:05E08-01 Autofluorescence Bronchoscopy and Optical Coherence Tomography
Stephen Lam (Canada)
16:35 E08-02 EBUS-TBNA: Real-time endobronchial ultrasound guided transbronchial needle aspiration
Takehiko Fujisawa (Japan)
17:05 E08-03 Innovative Bronchoscopic Diagnostic Techniques: Electromagnetic Navigation
Felix Herth (Germany)

Adjuvant Treatment for Resectable Lung Cancer
Session: E09
Chairs: Doo Yun Lee (South Korea) & Katherine MW. Pisters (USA)

16:05 E09-01 Adjuvant Treatment for Resectable Lung Cancer
Thierry Le Chevalier (UK)
16:20 E09-02 Japanese experience
Masahiro Tsuboi (Japan)
16:35 E09-03 Predictive marker for adjuvant treatment
Giorgio V. Scagliotti (Italy)
16:50 E09-04 Role of RT as an adjuvant treatment
Cecile Le Pechoux (France)
17:05 E09-05 Perspective for the use of targeted agents
Katherine MW. Pisters (USA)

Comprehensive Symptom Management in Advanced Lung Cancer
Session: E10
Chairs: Richard Gralla (USA) & Jeffrey Crawford (USA)

16:05 E10-01 Anemia
Robert Pirker (Austria)
16:20 E10-02 Neurotoxicity
Guido Cavaletti (Italy)
16:35 E10-03 Radiation Pneumonitis
Maria Werner-Wasik (USA)
16:50 E10-04 Pain control
Martin Muers (UK)
17:05 E10-05 Myelotoxicity
Jeffrey Crawford (USA)

Controversy in Small Cell Lung Cancer
Session: E11
Chairs: Chih-Hsin Yang (Taiwan) & Paul van Houtte (Belgium)

16:05 E11-01 Staging
Michael J. Millward (Australia)
16:25 E11-02 Controversies in the timing of chest radiotherapy
Paul Van Houtte (Belgium)
16:45 E11-03 Targeted therapy
Fiona Blackhall (UK)
17:05 E11-04 The role of irinotecan in the treatment of small cell lung cancer
Nasser H. Hanna (USA)

Recent Advances and Future Prospective in Lung Cancer Pathology
Session: E12
Chairs: William D. Travis (USA) & Masayuki Noguchi (Japan)

16:05 E12-01 CI Director's Challenge Gene Profiling of Lung Adenocarcinomas: Impact on Histologic Classification
William D. Travis (USA)
16:25 E12-02 Cytology and Fine Needle Aspiration Biopsy in the Diagnosis of Lung Cancer
Maureen Zakowski (USA)
16:45 E12-03 Intra-operative Pathology Consultation - Novel Approaches to Frozen Section
Andrew Nicholson (UK)
17:05 E12-04 Novel Histologic Criteria for Prognostication in Lung Adenocarcinoma
Masayuki Noguchi (Japan)

Insights into Thymic Epithelial Tumor
Session: E13
Chairs: Yung-Chie Lee (Taiwan) & Hans Konrad Müller-Hermelink (Germany)

16:05 E13-01 Pathology
Hans Konrad Müller-Hermelink (Germany)
16:20 E13-02 Imaging findings
Yeon Joo Jeong (South Korea)
16:35 E13-03 Outcome of surgical treatment for thymic epithelial tumors
Meinoshin Okumura (Japan)
16:50 E13-04 Radiation therapy
Charles Thomas, Jr. (USA)
17:05 E13-05 Chemotherapy
Tracey L. Evans (USA)

State-of-the-Art Innovation in Radiation Therapy
Session: E14
Chairs: Walter J. Curran (USA) & Yasushi Nagata (Japan)

16:05 E14-01 Image guided radiotherapy (IGRT); Physicist's Perspective
Paul Keall (USA)
16:25 E14-02 Stereotactic Body Radiotherapy for Lung Cancer
Yasushi Nagata (Japan)
16:45 E14-03 Image Guided (4D) Radiation Therapy
Dirk Verellen (Belgium)
17:05 E14-04 Particle Beam Therapy
Takashi Ogino (Japan)

PRESIDENTIAL SYMPOSIUM
Session: PRS
Chair: Desmond Carney (Ireland)
Co-Chair: Jin Soo Lee (South Korea)

08:20 PRS-01 The Epidemic of Smoking-Related Adenocarcinoma of the Lung: The Role of the Tobacco Industry and Filtered and Low-Tar Cigarettes
Gary Strauss, Tufts-New England Medical Center (USA)
Discussant: Tomotaka Sobue (Japan)

08:45 PRS-02 Gefitinib (IRESSA) versus docetaxel in patients with locally advanced or metastatic non-small-cell lung cancer pre-treated with platinum-based chemotherapy: a randomized, open-label Phase III study (INTEREST)
Jean-Yves Douillard (France)
Discussant: Frances Shepherd (Canada)

09:10 PRS-03 Phase III study of pemetrexed plus cisplatin versus gemcitabine plus cisplatin in chemonaive patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)
Giorgio Scagliotti, University of Turin, S. Luigi Hospital (Italy)
Discussant: Lawrence Einhorn (USA)

09:35 PRS-04 A phase III randomised, double blind, placebo controlled trial of etoposide/carboplatin with or without thalidomide in advanced small cell lung cancer (SCLC)
Siow-Ming Lee, University College London Hospitals NHS Trust (UK)
Discussant: Karen Kelly (USA)

Molecular Targeted Therapy: Beyond EGFR
Session: C1
Chair: Bruce Johnson (USA)
Co-Chair: Corey Langer (USA)

Staging Efficacy
Session: C2
Chair: J.A. Verschakelen (Belgium)
Co-Chair: Hyae Young Kim (South Korea)

Combined Modality Therapy in NSCLC II
Session: C3
Chair: Jack Roth (USA)
Co-Chair: Nevin Murray (Canada)

Chest Medicine
Session: C4
Chair: Eric S. Edell (USA)
Co-Chair: Stephen C. Lam (Canada)

Mesothelioma
Session: C5
Chair: Junji Yoshida (Japan)
Co-Chair: Antonio Torres Garcia

Cancer Genetics
Session: C6
Chair: Rafael Rossell (Spain)
Co-Chair: Sun Young Rha (South Korea)

Tumor & Cell biology
Session: C7
Chair: Mark G. Kris (USA)
Co-Chair: Kaoru Kubota (Japan)

Epidemiology & Tobacco control
Session: C8
Chair: Ellen Gritz (USA)
Co-Chair: Hong Kwan Seo (South Korea)

NSCLC-Surgery
Session: C9
Chair: Haruhiko Kondo (Japan)
Co-Chair: Jhingook Kim (South Korea)
Discussant: Jhingook Kim (South Korea)

GALA DINNER
Suggested Attire: Business
*Please bring your ticket for admission

Advanced Surgical Techniques
Session: MTP19
Chair: John C. Wain (USA)
MTP19-01 T4 N0/N1 Nonsmall cell lung cancer can be cured as a first line treatment with an expected five year survival rate as high as 43%
Professor: Philippe G. Dartevelle (France)

Image-Guided Radiation Therapy
Session: MTP20
Chair: Paul Van Houtte (Belgium)
MTP20-01 Image-Guided Radiation Therapy
Professor: James D. Cox (USA)

NSCLC Therapy: How much and how long?
Session: MTP21
Chair: James F. Bishop (Australia)
MTP21-01 Advanced NSCLC Chemotherapy: How Much and How Long?
Professor: Chandra P. Belani (USA)

Neuroendocrine Tumors
Session: MTP22
Chair: William D. Travis (USA)
MTP22-01 Neuroendocrine Tumors
Professor: Elisabeth Brambilla (France)

Salvage Therapy for NSCLC
Session: MTP23
Chair: Lucio Crino (Italy)
MTP23-01 Salvage Therapy For NSCLC
Professor: Tony Mok (China)

Targeting Angiogenesis
Session: MTP 24
Chair: Christian Manegold (Germany)
MTP24-01 Targeting Angiogenesis
Professor: Alan B. Sandler (USA)

PLENARY 3
Advances in Management of NSCLC
Session: PL3
Chairs: Paul Bunn, Jr. (USA) & Frances Shepherd (Canada)

08:20

08:45

09:10

09:35

PL3-01 Advances in Chemotherapy
David H. Johnson (USA)
PL3-02 Advances in Radiation Oncology
Suresh Senan (Netherlands)
PL3-03 Advances in Surgery for non small cell lung cancer
Hirohito Tada (Japan)
PL3-04 Advances in Molecular Targeted Therapy
Giuseppe Giaccone (USA)

HIGHLIGHT OF THE DAY
Session: HOD2
10:30 Pulmonology
Henri Colt (USA)
10:50 Tumor Biology
Pasi A. Janne (USA)
11:05 Novel Therapeutics
Wilfried Eberhardt (Germany)
11:25 Combined Modality
James Rigas (USA)
11:45 QOL/Supportive Care
Fergus Macbeth (UK)

How to Stage the Mediastinum
*Interactive Grand Round 4 Session: M14
Chairs: Young Mog Shim (South Korea) & Steven Keller (USA)

10:35 M14-01 Mediastinal Staging of NSCLC and FDG PET
Otto S. Hoekstra (Netherlands)
11:00 M14-02 EBUS/EUS
Mark Krasnik (Denmark)
11:25 M14-03 Mediastinoscopy
Kemp Kernstine (USA)

Genetics and Epigenetics in Lung Carcinogenesis
Session: M15
Chairs: Adi Gazdar (USA) & Christian Manegold (Germany)

10:35 M15-01 Integrating Epigenetic and Genetic Biomarkers for Early Lung Cancer Detection
Steve Belinsky (USA)
11:00 M15-02 Molecular pathogenesis of lung cancer and its precursor lesions
Adi Gazdar (USA)
11:30 M15-03 Molecular changes in invasion, tumor progression and metastasis
Ignacio I. Wistuba (USA)

Novel Vaccines and Immunotherapy
Session: M17
Chairs: Paul Bunn Jr. (USA) & Johan F. Vansteenkiste (Belgium)

10:35 M17-01 Immunotherapy for Lung Tumors
Eckhard Podack (USA)
10:50 M17-02 Immunotherapy of extensive stage small lung cancer with dendritic cell based P53 vaccines
Dimitri Gabrilovich (USA)
11:05 M17-03 Stimuvax (L-BLP25): A Peptide Vaccine Strategy in Non-Small Cell Lung Cancer
Charles Butts (Canada)
11:20 M17-04 T:R9 agonist
Vera Hirsh (Canada)
11:35 M17-05 MAGE-3-vaccine
Johan F. Vansteenkiste (Belgium)

Hot Issues in the Management of Brain Metastases
Session: M18
Chairs: Kwan Ho Cho (South Korea) & Rodrigo Arriagada (France)

10:35 M18-01 & M18-02 Brain metastases: Surgery versus Radiosurgery versus Whole brain irradiation
Frank J. Lagerwaard (Netherlands) & Kwan Ho Cho (South Korea)
11:15 M18-03 & M18-04 Treatment and Prevention of CNS metastases in NSCLC
Rodrigo Arriagada (France) & Elisabeth Gore (USA)

Bimodality vs. Trimodality in Stage III Non-Small Cell Lung Cancer
*Interactive Grand Round 5 Session: M19
Chairs: David Gandara (USA) & Joe B. Putnam (USA)

10:35 M19-01 Treatment of IIIA overview
Joe B. Putnam (USA)
11:00 M19-02 Bi-Modality versus Tri-Modality Therapy in Stage IIIa NSCLC: Where does the date leads us?
Andrew T. Turrisi (USA)
11:25 M19-03 Trimodality
Kathy S. Albain (USA)

Patients - Health Care Provider Communication
Session: M20
Chairs: Hoon Kyo Kim (South Korea) & William K. Evans (Canada)

10:35 M20-01 The cost of care for patients with lung cancer
Willam K. Evans (Canada)
10:55 M20-02 The organization for health services for patients with lung cancer
Anna Gregor (UK)
11:15 M20-03 Decision-making of lung cancer patients and family
Dae Seog Heo (South Korea)
11:35 M20-04 Desirable role of advocacy group
Laurie Fenton Ambrose (USA)

SCLC
Session: D1
Chair: Paul van Houtte (Belgium)
Co-Chair: Kazumasa Noda (Japan)

Molecular Targeted Therapy: Biomarkers
Session: D2
Chair: Fred R. Hirsch (USA)
Co-Chair: Vassilis Georgoulias (Greece)

Pharmacogenomics and Biomarker in Cytotocix Chemotherapy
Session: D3
Chair: Robert Pirker (Austria)
Co-Chair: Keunchil Park (South Korea)

Pathology
Session: D4
Chair: Elisabeth Brambilla (France)
Co-Chair: Kun Young Kwon (South Korea)

Prognostic Factors
Session: D5
Chair: Heung Tae Kim (South Korea)
Co-Chair: Mei Lin Liao (China)

Molecular Biology & Prognostic Factors
Session: D6
Chair: Adi Gazdar (USA)
Co-Chair: Geon Kook Lee (South Korea)

Novel therapeutics II
Session: D7
Chair: Pasi A. Janne (USA)
Co-Chair: Sang-We Kim (South Korea)

POSTER DISCUSSION SESSION 3
Session: PD3
Chair: Lucio Crino (Italy)
Co-Chair: Ramon Perez-Soler (USA)

PD3-1 Novel Therapeutics
Discussant: Faldo Khuri (USA)
PD3-2 Molecular Targeted Therapy: EGFR inhibitors
Discussant: Edward Kim (USA)
PD3-3 Molecular Targeted Therapy: Beyond EGFR inhibitors
Discussant: Antoinette Wozniak (USA)

POSTER DISCUSSION SESSION 5
Session: PD5
Chair: Fergus Macbeth (UK)
Co-Chair: Sook Whan Sung (South Korea)

PD5-1 Technical Advances on Radiation Therapy
Discussant: Zhongxing Liao (USA)
PD5-2 Clinical Data from Radiation Therapy
Discussant: Rene-Olivier Mirimanoff (Switzerland)
PD5-3 NSCLC-Surgery
Discussant: John C. Wain (USA)